Streetbeat News

Analyst Ratings

NVDA

TSLA

The popularity of AI stocks, particularly Nvidia Corp. (NASDAQ:NVDA), has surged, while interest in electric vehicle stocks like Tesla Inc. (NASDAQ:TSLA) has waned. Over the past year, Nvidia's price has increased by 233.6%, while Tesla's has fallen by 16.5%. Both companies do not pay dividends. Nvidia's PEG ratio suggests it is undervalued, while Tesla's indicates expected significant growth. Analyst consensus suggests a 39.5% upside for Nvidia and a 5.32% downside for Tesla.

Portfolio Pulse from Neer Varshney

September 28, 2023 | 4:40 pm

BNOX

HC Wainwright & Co. analyst Joseph Pantginis has upgraded Bionomics (NASDAQ:BNOX) from Neutral to Buy and announced a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 4:33 pm

MRNA

A whale investor has taken a bullish stance on Moderna (NASDAQ:MRNA), with 50% of investors opening trades with bullish expectations and 50% with bearish. The whale has been targeting a price range from $65.0 to $120.0 for Moderna over the last 3 months. Argus Research has maintained their Buy rating on Moderna, with a price target of $140.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 4:32 pm

INSW

BTIG analyst Gregory Lewis maintains a Buy rating on International Seaways (NYSE:INSW) and raises the price target from $45 to $55.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 4:27 pm

MPC

A significant bullish stance has been taken on Marathon Petroleum (NYSE:MPC) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split between 63% bullish and 36% bearish. The whales have been targeting a price range from $125.0 to $170.0 for Marathon Petroleum over the last 3 months. The price of MPC is up 1.73% at $155.06. Analysts from Mizuho, B of A Securities, Wells Fargo, and Raymond James have maintained their ratings on Marathon Petroleum.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 4:18 pm

NEE

Shares of NextEra Energy are trading lower following a series of price target reductions by multiple analysts.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 4:16 pm

BKNG

DA Davidson analyst Tom White maintains a Neutral rating on Booking Holdings (NASDAQ:BKNG) and raises the price target from $2700 to $3400.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 4:15 pm

CRWD

DA Davidson analyst Rudy Kessinger has reiterated a 'Buy' rating on CrowdStrike Holdings (NASDAQ:CRWD) and maintained a price target of $185.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 4:11 pm

AMZN

A survey by UK consumer body, Which?, revealed that around 10% of Amazon shoppers in Great Britain may have been offered bribes for positive product reviews. This has raised concerns about the credibility of online reviews on Amazon. The company's stock experienced a significant decline, gapping down over 2% on September 21st. Despite this, Amazon's overall stock performance has seen a substantial increase of 47% year to date, indicating potential for recovery and growth.

Portfolio Pulse from Zaheer Anwari

September 28, 2023 | 4:10 pm

IONS

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) announced that The Journal of the American Medical Association published positive results from the Phase 3 NEURO-TTRansform study of eplontersen, a treatment for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN). The study showed that eplontersen halted disease progression and improved quality of life at 35-, 66- and 85-week analyses. Ionis and AstraZeneca are seeking regulatory approval for eplontersen in the U.S. and other parts of the world. The FDA granted a PDUFA action date of Dec. 22, 2023.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 4:06 pm